Abstract
A facile one-pot synthesis of spirooxindolinopyrrolizidines incorporating the pyrene moiety was accomplished in good yields through a 1,3-dipolar cycloaddition reaction of 3-aryl-1-(pyren-1-yl)prop-2-en-1-one derivatives with in situ-generated azomethine ylides.
Introduction
The pyrene moiety is one of the most useful scaffolds for the construction of fluorogenic chemosensors for a diversity of important chemical species [1]. Multi-component 1,3-dipolar cycloaddition reactions are useful processes for building five-membered heterocyclic ring systems [2], [3], [4], [5], [6], [7], [8]. The azomethine ylides are reactive and versatile classes of 1,3-dipoles that can be readily trapped by many dipolarophiles [9], [10], [11], [12] to construct pyrrolidine, pyrrolizine and pyrrolothiazole derivatives. Such compounds are important bioactive agents that have glucosidase inhibitory activity as well as potent anti-inflammatory, antibacterial, antiviral, antidiabetic, anticancer and antitubercular activities [13], [14], [15], [16], [17]. However, there is little published work regarding the synthesis of spiroheterocyclic compounds which incorporate the pyrene moiety. Herein, in continuation of our previous work on the synthesis of bioactive spiroheterocycles [17], [18], [19], [20], [21], [22], [23], we report for the first time a convenient protocol for the synthesis of novel pyrene-incorporated spirooxindolinopyrrolizidines 6a–j via a 1,3-dipolar cycloaddition reaction involving the olefin segment of 3-aryl-1-(pyren-1-yl)prop-2-en-1-ones 3a–e and azomethine ylides that are generated by the decarboxylative condensation of indoline-2,3-diones 4a,b and proline (5). The generated azomethine ylides undergo the reaction with the dipolarophiles 3-aryl-1-(pyren-1-yl)prop-2-en-1-ones 3a–e regioselectively.
Results and discussion
The synthetic route to 3-aryl-1-(pyren-1-yl)prop-2-en-1-ones 3a–e is presented in Scheme 1. Acetylpyrene (2) was synthesized from pyrene by the classical Friedel-Crafts reaction according to the previously reported procedure with some modifications [1]. The dipolarophiles (E)-3-aryl-1-(pyren-1-yl)prop-2-en-1-ones 3a–e were obtained in good to excellent yields (75%–89%) through the Claisen-Schmidt condensation of acetylpyrene and aromatic aldehydes, namely benzaldehyde, 4-methoxybenzaldehyde, 4-(dimethylamino)-benzaldehyde, 4-chlorobenzaldehyde and 4-nitrobenzaldehyde in 2-propanol in the presence of potassium hydroxide as a catalyst. The chemical structures of compounds 3a–e were confirmed using spectroscopic and analytical tools.

Synthesis of compounds 6a–j.
In the preliminary work, a three-component reaction of (E)-3-phenyl-1-(pyren-1-yl)prop-2-en-1-one (3a), 1H-indoline-2,3-dione (4a) and proline (5) in various solvents including acetonitrile, ethanol, methanol, 2-propanol, dioxane and toluene under reflux conditions was investigated. The desired product 6a was obtained in good yields of up to 70% and 79% with a comparatively short reaction time (5 h) when the reaction was carried out in ethanol and methanol, respectively. Moderate yields of 61% and 66% were obtained when acetonitrile and 2-propanol were used, respectively. The yield decreased and a longer reaction time (7–8 h) was required for the reaction conducted in dioxane or toluene. This result is consistent with a polar transition state that is stabilized in polar solvents.
A series of novel pyrene-substituted spirooxindolinopyrrolizidines were synthesized by the reaction of various (E)-3-aryl-1-(pyren-1-yl)prop-2-en-1-ones 3a–e with azomethine ylides generated from 1H-indoline-2,3-dione (4a) or N-methylindoline-2,3-dione (4b) and proline (5). Under optimized conditions, the reaction proceeds smoothly to afford spiro[2.3′]-oxindoline-4-aryl-3-(1-pyrenoyl)pyrrolizidine 6a–j in good yields (74%–84%).
As suggested in Scheme 2, the reaction proceeds through the generation of an azomethine ylide via the decarboxylative condensation of indoline-2,3-diones 4a,b with proline (5).

Formation of azomethine ylide.
Although two diastereomers were obtained in each case, the reaction is regioselective, with the transition state suggested in Scheme 3. The regioselectivity in the product formation can be explained by considering a secondary interaction of the orbital of the carbonyl group of dipolarophile 3a–e with those of the azomethine ylide as shown in Scheme 3 [24].

Transition states and stereochemistry of the cycloadducts 6a–j.
Accordingly, the observed regioisomer, spiro[2.3′]-oxindoline-4-(aryl)-3-pyrenoyl-pyrrolizidine 6a–j, is formed via path A, the transition states I and II of which are more favorable than the alternative transition state that would lead to hypothetical product 7a–j. In addition, favorable secondary orbital interactions can be suggested for path A, which are not possible in path B.
The formation of two diastereoisomeric products is consistent with the results of the theoretical studies using GAMESS interface v.11.0. (CambridgeSoft). The calculation showed that the major diasteromer (77%) with a lower total energy of −3.0552 kcal mol−1 and heat of formation of ΔH=56.0714 kcal mol−1 is formed through transition state I, in which two carbonyl groups linked to C-2 and C-3 are anti to each other. This arrangement is translated into trans stereochemistry in the cycloadduct 6. By contrast, the two carbonyl groups are syn to each other in transition state II, leading to the minor diasteromer (23%) with higher total energy and heat of formation due to electrostatic repulsion between the cis carbonyl groups (Scheme 3) [25].
As indicated by the analysis of the 1H NMR data, the products 6a–j are mixtures of diastereomers in the ratio of 77:23 in each case. Some of the proton signals of the minor stereoisomers overlap with the NMR signals of the major diastereomers. Due to this spectral complexity, the given NMR data are for the major isomers. Signals of the methine protons attached to the stereogenic centers proved helpful in assigning relative stereochemistry. In particular, the 1H NMR and two-dimensional (2D) correlation studies (COSY, HSQC, HMBC) of 6b enabled an accurate identification of the methine protons that resonate as a doublet at 5.23 ppm (J=14.1 Hz) for the downfield 3-CH proton. The 4-CH proton exhibits a triplet at 4.00 ppm (J=14.1 Hz), whereas the 4a-CH proton exhibits a broad multiplet in the region of 3.91–3.93 ppm. The observed coupling constant value between the vicinal methine protons clearly indicates a large dihedral angel due to vicinal trans protons. On the other hand, two multiplets in the regions of 1.73–1.88 ppm and 2.34–2.42 ppm for 6-CH2, 5-CH2 and 7-CH2 protons can be observed. The methoxy group exhibits a singlet at 3.73 ppm. These data are consistent with the formation of a single regioisomer 6 in each case. The deshielding effect in the hypothetical regioisomer 7 would be expected to result in the formation of a doublet of doublets (dd) instead of the observed doublet for the downfield C-H proton of the pyrrolizidine moiety.
Analysis of the 13C NMR spectrum of 6b added conclusive support to the proposed structure. The spiro carbon resonates at 73.2 ppm. The indoline carbonyl carbon and the carbonyl carbon resonate at 179.0 and 200.1 ppm, respectively. The signals at 27.7, 30.8, 47.5, 49.1, 51.7, 55.4, and 65.9 ppm can be assigned to 6-CH2, 5-CH2, 7-CH2, 4-CH, CH3, 3-CH, 4a-CH and 3-CH carbons, respectively (see Supplementary Material).
Conclusions
Novel pyrene-bearing mono spirooxindolinopyrrolizidines were synthesized in good yields through the [3+2]-cycloaddition of azomethine ylides generated in situ via the decarboxylative condensation of indoline-2,3-dione derivatives and proline with l-pyrene dipolarophiles.
Experimental
Melting points are not corrected. FT-IR spectra were recorded on a Shimadzu IR-3600 spectrometer in KBr pellets. 1H NMR spectra (500 MHz) and 13C NMR spectra (125 MHz) were recorded on a Bruker Avance 500 spectrometer in chloroform-d or dimethyl sulfoxide–d6. Elemental analyses (C, H, N and Cl) were performed on a Vario EL V2.3 analyzer.
Synthesis of the dipolarophiles 3-aryl-1-(pyren-1-yl)prop-2-en-1-ones 3a–e
A 50-mL round-bottom flask was charged with acetylpyrene (244 mg, 1.0 mmol), the appropriate aromatic aldehyde [benzaldehyde, 4-methoxybenzaldehyde, 4-(dimethylamino)-benzaldehyde, 4-chlorobenzaldehyde or 4-nitrobenzaldehyde, 1 mmol each], 2-propanol (10 mL) and aqueous KOH (20%). The mixture was stirred at room temperature for 1.5–3 h (monitored by TLC using CH2Cl2 as an eluent). The formed precipitate was filtered off, dried and crystallized from 2-propanol to afford chalcone 3a–e.
3-Phenyl-1-(pyren-1-yl)prop-2-en-1-ones (3a)
80% yield of orange crystals; mp 215–217°C; IR: ύ 3030 (CH arom.), 1675 (C=O) cm−1; 1H NMR (CDCl3): δ 7.43–7.48 (m, 3H, Ph-H), 7.50 (d, 1H, Hb, J=14.7 Hz), 7.60–7.64 (m, 2H, Ph-H), 7.68 (d, 1H, Ha, J=14.7 Hz), 8.03–8.20 (m, 4H, pyrene-H), 8.22 (d, 1H, pyrene-H, J=10.0 Hz), 8.24–8.30 (m, 3H, pyrene-H), 8.64 (d, 1H, pyrene-H, J=10.0 Hz); 13C NMR (CDCl3): δ 120.6, 123.2, 124.4, 126.0, 126.2, 126.3, 126.8, 127.4, 127.5, 127.7, 128.5, 128.9, 129.1, 129.2, 129.4, 129.7, 130.3, 130.5, 130.7, 134.5, 146.5, 148.0, 196.0. Anal. Calcd. for C25H16O: C, 90.33; H, 4.85. Found: C, 90.45; H, 4.93.
3-(4-Methoxyphenyl)-1-(pyren-1-yl)prop-2-en-1-ones (3b)
89% yield of orange crystals; mp 196–198°C; IR: ύ 3037 (CH arom.), 1666 (C=O) cm−1; 1H NMR (CDCl3): δ 3.78 (s, 3H, CH3), 6.96 (d, 2H, Ph-H, J=10.1 Hz), 7.55–7.58 (m, 2H, Hb + pyrene-H), 7.73 (d, 2H, Ph-H, J=10.1 Hz), 8.11 (d, 1H, Ha, J=9.2 Hz), 8.22–8.27 (m, 3H, pyrene-H), 8.32–8.37 (m, 4H, pyrene-H), 8.56 (d, 1H, pyrene-H, J=11.3 Hz); 13C NMR (CDCl3): δ 60.5, 118.8, 119.6, 129.6, 129.9, 131.1, 131.4, 131.6, 131.9, 132.4, 134.1, 134.2, 136.0, 150.6, 166.7, 199.5. Anal. Calcd. for C26H18O2: C, 86.16; H, 5.01. Found: C, 86.30; H, 5.26.
3-(4-Dimethylaminophenyl)-1-(pyren-1-yl)prop-2-en-1-ones (3c)
75% yield of red crystals; mp 220–222°C; IR: ύ 3035 (CH arom.), 1670 (C=O) cm−1; 1H NMR (CDCl3): δ 3.04 (s, 6H, 2CH3), 6.70 (d, 2H, Ph-H, J=10.0 Hz), 7.26 (d, 1H, Hb, J=14.8 Hz), 7.49 (d, 2H, Ph-H, J=10.0 Hz), 7.57 (d, 1H, Ha, J=14.8 Hz), 8.01–8.28 (m, 8H, pyrene-H), 8.57 (d, 1H, pyrene-H, J=11.3 Hz); 13C NMR (CDCl3): δ 40.2, 112.0, 122.9, 124.1, 124.5, 124.6, 124.9, 125.7, 125.8, 125.9, 126.2, 127.0, 127.2, 128.6, 129.2, 130.5, 130.8, 131.1, 132.2, 135.1, 147.5, 196.6. Anal. Calcd. for C27H21NO: C, 86.37; H, 5.64; N, 3.73. Found: C, 86.09; H, 5.70; N, 3.88.
3-(4-Chlorophenyl)-1-(pyren-1-yl)prop-2-en-1-ones (3d)
81% yield of yellow crystals; mp 200–202°C; IR: ύ 3038 (CH arom.), 1680 (C=O) cm−1; 1H NMR (CDCl3): δ 7.46 (d, 2H, Ph-H, J=10.0 Hz), 8.04–8.40 (m, 9H, pyrene-H), 8.41 (d, 1H, Hb, J=11.4 Hz), 8.64 (d, 2H, Ph-H, J=11.1 Hz), 9.09 (d, 1H, Hb, J=11.4 Hz); 13C NMR (CDCl3): δ 124.0, 124.5, 124.9, 125.0, 126.0, 126.1, 126.3, 126.4, 127.0, 127.1, 128.8, 129.1, 129.6, 130.5, 131.5, 131.9, 132.2, 133.8, 134.0, 141.9, 169.4, 202.9. Anal. Calcd. for C25H15ClO: C, 81.85; H, 4.12; Cl, 9.66. Found: C, 82.12; H, 4.40; Cl, 9.70.
3-(4-Nitrophenyl)-1-(pyren-1-yl)prop-2-en-1-ones (3e)
87% yield of pale brown crystals; mp 241–242°C; IR: ύ 3038 (CH arom.), 1685 (C=O) cm−1; 1H NMR (CDCl3): δ 7.52 (d, 2H, Ph-H, J=10.0 Hz), 7.62 (d, 2H, Ph-H, J=10.0 Hz), 7.66 (d, 1H, Hb, J=11.4 Hz), 8.08–8.33 (m, 9H, pyrene-H), 8.71 (d, 1H, Ha, J=11.4 Hz); 13C NMR (CDCl3): δ 123.6, 123.8, 124.1, 124.3, 124.4, 125.5, 126.2, 126.5, 126.7, 128.1, 128.9, 130.6, 130.9, 132.7, 142.6, 146.9, 148.6, 194.5. Anal. Calcd. for C25H15NO3: C, 79.56; H, 4.01; N, 3.71. Found: C, 79.40; H, 4.20; N, 3.96.
General procedure for the synthesis of pyrene bearing monospiro-oxindolino- pyrrolizidines 6a–j
A mixture of the appropriate dipolarophile 3a–e (1 mmol), 4a,b (1.1 mmol), proline (126 mg, 1.1 mmol) and methanol (10 mL) was heated under reflux for 4–9 h. Upon completion of the reaction, as monitored by TLC using CH2Cl2 as the eluent, the mixture was cooled to room temperature. The resultant solid product was filtered off and crystallized from methanol.
Spiro[2.3′]oxoindoline-4-phenyl-3-(1-pyrenoyl)pyrrolizidine (6a)
Pale yellow crystals; mp 180–182°C; IR: ύ 3209 (NH), 3026 (CH arom.), 2960 (CH aliph.), 1701 (C=O), 1697 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.40–2.00 (m, 4H, 6-CH2, 5-CH2), 2.25–2.45 (m, 2H, 7-CH2), 3.35 (t, 1H, 4-CH, J=11.3 Hz), 3.60–3.75 (m, 1H, 4a-CH), 5.25 (d, 1H, 3-CH, J=11.3 Hz), 6.10–6.40 (m, 1H, Ar-H), 6.75–7.40 (m,9H, Ar-H), 7.50–7.75 (m, 2H, Ar-H), 8.00–8.50 (m, 6H, Ar-H), 10.25 (s, 1H, NH); 13C NMR (DMSO-d6): δ 20.5, 27.3, 30.4, 47.0, 52.0, 67.6, 72.7, 108.8, 109.3, 109.9, 120.8, 121.1, 123.5, 124.4, 125.9, 126.6, 127.2, 127.8, 128.7, 128.9, 129.0, 129.9, 130.6, 132.1, 133.0, 140.3, 142.3, 142.7, 178.5, 203.4. Anal. Calcd. for C37H28N2O2: C, 83.43; H, 5.30; N, 5.26. Found: C, 83.66; H, 5.45; N, 5.15.
Spiro[2.3′]oxoindoline-4-(4-methoxyphenyl)-3-(1-pyrenoyl)pyrrolizidine (6b)
Orange crystals; mp 166–167°C; IR: ύ 3030 (CH arom.), 2945 (CH aliph), 1708 (C=O), 1676 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.73–1.88 (m, 4H, 5-CH2, 6-CH2), 2.34–2.42 (m, 2H, 7-CH2), 3.73 (s, 3H, CH3), 3.91–3.93 (m, 1H, 4a-CH), 4.00 (t, 1H, 4-CH, J=14.1 Hz), 5.23 (d, 1H, 3-CH, J=14.1 Hz), 6.97 (d, 2H, Ph-H, J=10.0 Hz), 7.09–7.15 (m, 2H, indoline-H), 7.24 (d, 2H, Ph-H, J=10.0 Hz), 7.59–7.81 (m, 2H, indoline-H), 8.07–8.32 (m, 9H, pyrene-H), 9.61 (s, 1H, NH); 13C NMR (DMSO-d6): δ 27.7, 30.8, 47.5, 49.1, 51.7, 55.4, 65.9, 73.2, 110.3, 114.5, 121.6, 124.1, 124.5, 126.3, 126.9, 127.0, 128.6, 129.2, 132.7, 133.5, 142.4, 158.5, 179.0, 200.1. Anal. Calcd. for C38H30N2O3: C, 81.12; H, 5.37; N, 4.98. Found: C, 81.00; H, 5.58; N, 4.70.
Spiro[2.3′]oxoindoline-4-(4-dimethylaminophenyl)-3-(1-pyrenoyl)pyrrolizidine (6c)
Orange crystals; mp 174–176°C; IR: ύ 3206 (NH), 3035 (CH arom.), 2957 (aliph.), 1701 (C=O), 1697 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.25–2.05 (m, 4H, 6-CH2, 5CH2), 2.38–2.40 (m, 2H, 7-CH2), 2.52 (t, 1H, 4-CH, J=11.4 Hz), 3.52 (s, 6H, 2CH3), 3.75–3.95 (m, 1H, 4a-CH), 5.30 (d, 1H, 3-CH, J=11.4 Hz), 7.04–7.96 (m, 8H, Ar-H), 8.00–8.41 (m, 9H, Ar-H), 10.24 (s, 1H, NH) ppm; 13C NMR (DMSO-d6): δ 27.6, 30.4, 47.4, 52.1, 65.6, 72.4, 73.3, 76.1, 110.3, 121.9, 124.1, 124.8, 126.3, 126.9, 127.1, 127.6, 127.7, 128.7, 129.9, 130.1, 130.9, 133.6, 134.2, 142.1, 146.8, 148.9, 149.3, 179.3, 199.8. Anal. Calcd. for C39H33N3O2: C, 81.37; H, 5.78; N, 7.30. Found: C, 81.45; H, 5.82; N, 7.61.
Spiro[2.3′]oxoindoline-4-(4-chlorophenyl)-3-(1-pyrenoyl)pyrrolizidine (6d)
Pale yellow crystals; mp 170–171°C; IR: ύ 3225 (NH), 3097 (CH arom.), 2966 (CH aliph.), 1708 (C=O), 1684 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.25–2.00 (m,4H, 6-CH2, 5-CH2), 2.28–2.43 (m, 2H, 7-CH2), 2.96 (t, 1H, 4-CH, J=11.1 Hz), 3.43–3.62 (m, 1H, 4a-CH), 5.58 (d, 1H, 3-CH, J=11.1 Hz), 6.40–6.80 (m, 4H, indoline-H), 6.90–7.20 (m, 4H, pyrene-H), 7.15 (d, 2H, Ph-H, J=10.0 Hz), 7.30–7.40 (m, 1H, pyrene-H), 7.45 (d, 2H, Ph-H, J=10.0 Hz), 7.50–7.60 (m, 3H, pyrene-H), 7.74–7.82 (m, 1H, pyrene-H), 9.90 (s, 1H, NH); 13C NMR (DMSO-d6): δ 27.5, 30.9, 45.9, 51.8, 56.5, 65.2, 72.5, 110.3, 112.2, 113.2, 121.6, 124.2, 124.9, 125.5, 126.4, 127.7, 127.8, 128.7, 129.5, 130.3, 131.1, 142.4, 147.3, 149.9, 160.9, 177.3, 196.5. Anal. Calcd. for C37H27ClN2O2: C, 78.37; H, 4.80; N, 4.94; Cl, 6.25. Found: C, 78.45; H, 5.00; N, 4.80; Cl, 6.40.
Spiro[2.3′]oxoindoline-4-(4-nitrophenyl)-3-(1-pyrenoyl)pyrrolizidine (6e)
Pale brown crystals; mp 189–190°C; IR: ύ 3201 (NH), 3035 (CH arom.), 2957 (CH aliph.), 1708 (C=O), 1684 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.25–2.01 (m,4H, 6-CH2, 5-CH2), 2.30–2.45 (m, 2H, 7-CH2), 2.90 (t, 1H, 4-CH, J=11.1 Hz), 3.46–3.66 (m, 1H, 4a-CH), 5.15 (d, 1H, 3-CH, J=11.1 Hz), 6.44–6.85 (m, 4H, indoline-H), 6.90–7.19 (m, 4H, pyrene-H), 7.20 (d, 2H, Ph-H, J=10.0 Hz), 7.25–7.40 (m, 1H, pyrene-H), 7.44 (d, 2H, Ph-H, J=10.0 Hz), 7.50–7.61 (m, 3H, pyrene-H), 7.79–7.85 (m, 1H, pyrene-H), 9.59 (s, 1H, NH); 13C NMR (DMSO-d6): δ 27.7, 30.9, 47.5, 51.8, 56.5, 66.0, 72.5, 110.3, 112.2, 113.2, 121.6, 124.1, 124.9, 125.5, 126.4, 127.7, 127.8, 128.7, 129.5, 130.3, 131.1, 142.3, 147.3, 149.9, 169.9, 179.0, 200.2. Anal. Calcd. for C37H27N3O4: C, 76.93; H, 4.71; N, 7.27. Found: C, 77.15; H, 4.80; N, 7.40.
Spiro[2.3′]oxoindoline-1′-methyl-4-phenyl-3-(1-pyrenoyl)pyrrolizidine (6f)
Pale yellow crystals; mp 161–163°C; IR: ύ 3043 (CH arom.), 2951 (CH aliph.), 1706 (C=O), 1665 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.40–2.00 (m, 4H, 6-CH2, 5-CH2), 2.25–2.45 (m, 2H, 7-CH2), 3.35 (t, 1H, 4-CH, J=14.1 Hz), 3.41 (s, 3H, CH3), 3.60–3.75 (m, 1H, 4a-CH), 5.25 (d, 1H, 3-CH, J=14.1 Hz), 6.10–6.40 (m, 1H, Ar-H), 6.75–7.40 (m, 9H, Ar-H), 7.50–7.75 (m, 2H, Ar-H), 8.00–8.50 (m, 6H, Ar-H); 13C NMR (DMSO-d6): δ=20.5, 27.3, 30.4, 47.0, 52.0, 56.3, 58.3, 72.7, 108.8, 109.3, 109.9, 120.8, 121.1, 123.5, 124.4, 125.9, 126.6, 127.8, 128.7, 128.9, 129.9, 130.6, 132.1, 133.0, 140.3, 142.3, 142.7, 178.5, 203.4. Anal. Calcd. for C38H30N2O2: C, 83.49; H, 5.53; N, 5.12. Found: C, 83.70; H, 5.30; N, 5.41.
Spiro[2.3′]oxoindoline-1′-methyl-4-(4-methoxyphenyl)-3-(1-pyrenoyl)pyrrolizidine (6g)
Orange crystals; mp 160–162°C; IR: ύ 3043 (CH arom.), 2947 (CH aliph.), 1705 (C=O), 1692 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.40–1.70 (m, 2H, 6-CH2), 2.30–2.45 (m, 2H, 5-CH2), 3.11–3.47 (m, 2H, 7-CH2), 3.62 (t, 1H, 4-CH, J=14.1 Hz), 3.69 (s, 3H, CH3), 3.70–3.85 (m, 4H, 4a-CH, CH3), 5.06 (d, 1H, 3-CH, J=14.1 Hz), 6.23 (d, 2H, Ph-H, J=9.0 Hz), 6.77 (d, 2H, Ph-H, J=9.0 Hz), 6.95–7.25 (m, 4H, indoline-H), 7.57 (m, 1H, pyrene-H), 7.73–7.78 (m, 1H, pyrene-H), 8.02–8.19 (m, 7H, pyrene-H); 13C NMR (DMSO-d6): δ 27.7, 30.8, 36.5, 48.0, 51.7, 55.4, 66.0, 72.6, 73.1, 110.3, 113.8, 114.8, 114.9, 121.6, 124.7, 126.4, 127.6, 128.0, 129.2, 129.4, 129.8, 130.4, 131.8, 133.5, 134.0, 142.4, 146.0, 158.6, 177.6, 199.6, 202.9. Anal. Calcd. for C39H32N2O3: C, 81.23; H, 5.59; N, 4.86. Found: C, 81.45; H, 5.62; N, 5.00.
Spiro[2.3′]oxoindoline-1′-methyl-4-(4-dimethylaminophenyl)-3-(1-pyrenoyl)pyrrolizidine (6h)
Orange crystals; mp 163–165°C; IR: ύ 3043 (CH arom.), 2969 (CH arom.), 1706 (C=O), 1690 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.26–2.15 (m, 4H, 6-CH2, 5CH2), 2.38–2.42 (m, 2H, 7-CH2), 2.80 (t, 1H, 4-CH, J=11.2 Hz), 3.51 (s, 6H, 2CH3), 3.65–3.90 (m, 4H, 4a-CH, CH3), 5.30 (d, 1H, 3-CH, J=11.2 Hz), 7.15–7.95 (m, 8H, Ar-H), 8.00–8.45 (m, 9H, Ar-H); 13C NMR (DMSO-d6): δ 27.6, 30.4, 36.2, 47.2, 52.1, 65.7, 72.4, 73.3, 76.1, 110.2, 121.9, 123.7, 124.1, 124.9, 125.7, 126.9, 127.1, 127.6, 127.7, 128.7, 129.7, 129.8, 129.9, 130.1, 130.3, 130.9, 131.0, 133.6, 134.2, 142.1, 146.8, 148.9, 149.3, 179.5, 200.2. Anal. Calcd. for C40H35N3O2: C, 81.47; H, 5.98; N, 7.13. Found: C, 81.60; H, 6.21; N, 7.00.
Spiro[2.3′]oxoindoline-1′-methyl-4-(4-chlorophenyl)-3-(1-pyrenoyl)pyrrolizidine (6i)
Yellow crystals; mp 159–160°C; IR: ύ 3035 (CH arom.), 2965 (CH arom.), 1702 (C=O), 1693 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.25–2.00 (m,4H, 6-CH2, 5-CH2), 2.25–2.40 (m, 2H, 7-CH2), 2.74 (t, 1H, 4-CH, J=11.2 Hz), 3.47–3.60 (m, 4H, 4a-CH, CH3), 5.20 (d, 1H, 3-CH, J=11.2 Hz), 6.42–6.81 (m, 4H, indoline-H), 6.90–7.20 (m, 4H, pyrene-H), 7.13 (d, 2H, Ph-H, J=10.0 Hz), 7.30–7.40 (m, 1H, pyrene-H), 7.47 (d, 2H, Ph-H, J=10.0 Hz), 7.50–7.60 (m, 3H, pyrene-H), 7.74–7.82 (m, 1H, pyrene-H); 13C NMR (DMSO-d6): δ 27.3, 30.9, 46.0, 51.8, 56.5, 65.2, 72.5, 73.2, 110.3, 112.2, 113.2, 120.6, 124.2, 124.9, 125.5, 126.4, 127.0, 127.8, 128.7, 129.2, 129.5, 130.3, 131.1, 142.4, 147.3, 149.9, 155.7, 179.3, 200.0. Anal. Calcd. for C38H29ClN2O2: C, 78.54; H, 5.03; N, 4.82; Cl, 6.10. Found: C, 78.36; H, 4.88; N, 4.56; Cl, 5.89.
Spiro[2.3′]oxoindoline-1′-methyl-4-(4-nitrophenyl)-3-(1-pyrenoyl)pyrrolizidine (6j)
Pale brown crystals; mp 177–179°C; IR: ύ 3039 (CH arom.), 2963 (CH aliph.), 1702 (C=O), 1689 (C=O) cm−1; 1H NMR (DMSO-d6): δ 1.26–2.11 (m,4H, 6-CH2, 5-CH2), 2.30–2.45 (m, 2H, 7-CH2), 3.15 (t, 1H, 4-CH, J=11.1 Hz), 3.45–3.65 (m, 4H, 4a-CH, CH3), 5.25 (d, 1H, 3-CH, J=11.1 Hz), 6.45–6.85 (m, 4H, indoline-H), 6.90–7.20 (m, 4H, pyrene-H), 7.27 (d, 2H, Ph-H, J=10.0 Hz), 7.29–7.38 (m, 1H, pyrene-H), 7.42 (d, 2H, Ph-H, J=10.0 Hz), 7.50–7.61 (m, 3H, pyrene-H), 7.76–7.91 (m, 1H, pyrene-H); 13C NMR (DMSO-d6): δ 27.7, 30.9, 35.8, 47.4, 51.8, 56.5, 66.0, 73.2, 110.3, 112.2, 113.1, 121.6, 124.0, 124.9, 125.5, 126.4, 127.7, 128.7, 129.2, 129.5, 130.3, 131.0, 142.3, 147.3, 149.9, 167.9, 179.7, 201.5. Anal. Calcd. for C38H29N3O4: C, 77.14; H, 4.94; N, 7.10. Found: C, 76.90; H, 5.10; N, 6.88.
References
[1] Weng, J.; Mei, Q.; Ling, Q. Q.; Fan, Q.; Huang, W. A new colorimetric and fluorescent ratiometric sensor for Hg2+ based on 4-pyren-1-yl-pyrimidine. Tetrahedron2012, 68, 3129–3134.10.1016/j.tet.2011.12.071Search in Google Scholar
[2] Tsuge, O.; Kanemasa, S. Recent Advances in Azomethine Ylide Chemistry. In Advances in Heterocyclic Chemistry. Katritzky, A. R., Ed. Academic: San Diego, 1989; Vol. 45, pp 231–252.10.1016/S0065-2725(08)60332-3Search in Google Scholar
[3] Grigg, R. Prototropic routes to 1,3- and 1,5-dipoles and 1,2-ylides: applications to the synthesis of heterocyclic compounds. Chem. Soc. Rev. 1987, 16, 89–121.10.1039/cs9871600089Search in Google Scholar
[4] Shi, F.; Mancuso, R.; Larock, R. C. 1,3-Dipolar cycloaddition of arynes with azomethine imines: synthesis of 1,2-dihydropyrazolo[1,2-a]indazol-3(9H)-ones. Tetrahedron Lett. 2009, 50, 4067–4070.10.1016/j.tetlet.2009.04.102Search in Google Scholar PubMed PubMed Central
[5] Shi, F.; Zhu, R.; Liang, X.; Tu, S. Catalytic asymmetric 1,3-dipolar cycloadditions of alkynes with isatin-derived azomethine ylides: enantioselective synthesis of spiro[indoline-3,2′-pyrrole] derivatives. Adv. Synth. Catal.2013, 355, 2447–2458.10.1002/adsc.201300366Search in Google Scholar
[6] Wang, C.; Zhu, R.; Zheng, J.; Shi, F.; Tu, S. Enantioselective construction of spiro[indoline-3,2′-pyrrole] framework via catalytic asymmetric 1,3-dipolar cycloadditions using allenes as equivalents of alkynes. J. Org. Chem.2015, 80, 512–520.10.1021/jo502516eSearch in Google Scholar PubMed
[7] Dai, W.; Jiang, X.; Wu, Q.; Shi, F.; Tu, S. Diastereo- and enantioselective construction of 3,3′-pyrrolidinyldispirooxindole framework via catalytic asymmetric 1,3-dipolar cycloadditions. J. Org. Chem.2015, 80, 5737–5744.10.1021/acs.joc.5b00708Search in Google Scholar PubMed
[8] Wang, Y.; Zhang, H.; Li, C.; Fan, T.; Shi, F. Catalytic asymmetric chemoselective 1,3-dipolar cycloadditions of azomethine ylide with isatin derived imines: diastereo- and enantioselective construction of spiro[imidazolidine-2,3′-oxindole] framework. Chem. Commun.2016, 52, 1804–1807.10.1039/C5CC07924ASearch in Google Scholar PubMed
[9] Nair, V.; Suja, T. D. Intramolecular 1,3-dipolar cycloaddition reactions in targeted syntheses. Tetrahedron2007, 63, 12247–12275.10.1016/j.tet.2007.09.065Search in Google Scholar
[10] Ghandi, M.; Yari, A.; Rezaei, S. J. T.; Taheri, A. Synthesis of novel spiropyrrolidine/pyrrolizine-oxindole scaffolds through 1,3-dipolar cycloadditions. Tetrahedron Lett.2009, 50, 4724–4726.10.1016/j.tetlet.2009.06.033Search in Google Scholar
[11] Ahrendt, K. A.; Williams, R. M. A concise asymmetric synthesis of the ADE fragment of nakadomarin A. Org Lett. 2004, 6, 4539–4541.10.1021/ol048126eSearch in Google Scholar PubMed
[12] Karthikeyan, S. V.; Bala, B. D.; Raja, V. P. A.; Perumal, S.; Yogeeswari, P.; Sriram, D. A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents. Bioorg. Med. Chem. Lett.2010, 20, 350–353.10.1016/j.bmcl.2009.10.107Search in Google Scholar PubMed
[13] Murugan, S. R.; Anbazhagan, S.; Narayanan, S. Synthesis and in vivo antidiabetic activity of novel dispiropyrrolidines through [3+2] cycloaddition reactions with thiazolidinedione and rhodanine derivatives. Eur. J. Med. Chem.2009, 44, 3272–3279.10.1016/j.ejmech.2009.03.035Search in Google Scholar PubMed
[14] Karthikeyan, K.; Kumar, R. S.; Muralidharan, D.; Perumal, P. T. Diastereoselective synthesis of pyrrolidines via 1,3-dipolar cycloaddition of a chiral azomethine ylide. Tetrahedron Lett.2009, 50, 7175–7179.10.1016/j.tetlet.2009.10.030Search in Google Scholar
[15] Girgis, A. S. Regioselective synthesis of dispiro[1H-indene-2,3′-pyrrolidine-2′,3″-[3H]indole]-1,2″(1″H)-diones of potential anti-tumor properties. Eur. J. Med. Chem.2009, 44, 91–100.10.1016/j.ejmech.2008.03.013Search in Google Scholar PubMed
[16] Kumar, R. R.; Manju, S. P. S. C.; Bhatt, P.; Yogeeswari, P.; Sriram, D. An atom economic synthesis and antitubercular evaluation of novel spiro-cyclohexanones. Bioorg. Med. Chem. Lett.2009, 19, 3461–3465.10.1016/j.bmcl.2009.05.018Search in Google Scholar PubMed
[17] Hussein, E. M.; Abdel-Monem, M. I. Regioselective synthesis and anti-inflammatory activity of novel dispiro [pyrazolidine-4,3′-pyrrolidine-2′,3″-indoline]-2″,3,5-triones. Arkivoc2011, 10, 85–98.10.3998/ark.5550190.0012.a07Search in Google Scholar
[18] Hussein, E. M.; El-Khawaga, A. M. Simple and clean procedure for three-component syntheses of spiro{pyrido[2,1-b]benzothiazole-3,3′-indolines} and spiro{thiazolo[3,2-a]pyridine-7,3′-indolines} in aqueous medium. J. Heterocycl. Chem. 2012, 49, 1296–1301.10.1002/jhet.908Search in Google Scholar
[19] Abdel-Mohsen, S. A.; Hussein, E. M. A green synthetic approach to the synthesis of Schiff bases from 4-amino-2-thioxo-1,3-diazaspiro[5.5]undec-4-ene-5-carbonitrile as potential anti-inflammatory agents. Russ. J. Bioorg. Chem.2014, 40, 343–349.10.1134/S1068162014030029Search in Google Scholar
[20] Hussein, E. M.; Masaret, G. S.; Khairou, K. S. Efficient synthesis and antimicrobial evaluation of some Mannich bases from 2-arylidine-1-thia-4-azaspiro[4.5] decan-3-ones. Chem. Cent. J.2015, 9, 25.10.1186/s13065-015-0101-8Search in Google Scholar PubMed PubMed Central
[21] Hussein, E. M.; Al-Shareef, H. F.; Aboellil, A. H.; Elhady, H. A. Synthesis of some novel 6′-(4-chlorophenyl)-3,4′-bipyridine-3′-carbonitriles: assessment of their antimicrobial and cytotoxic activity. Z. Naturforsch. B.2015, 70, 783–795.10.1515/znb-2015-0065Search in Google Scholar
[22] Al-Shareef, H. F.; Aboellil, A. H.; Elhady, H. A.; Hussein, E. M. Ammonium chloride catalyzed synthesis of novel Schiff bases from spiro[indoline-3,4′-pyran]-3′-carbonitriles and evaluation of their antimicrobial and anti-breast cancer activities. SpringerPlus.2016, 5, 887.10.1186/s40064-016-2458-0Search in Google Scholar PubMed PubMed Central
[23] Abdel-Rahman, M. A.; Hussein, E. M.; Hussein, M. A. Synthesis and characterization of novel anti-inflammatory poly(spirothiazolidinone)s. Des. Monomers Polym.2016, 19, 650–660.10.1080/15685551.2016.1198881Search in Google Scholar
[24] Pardasani, R. T.; Pardasani, P.; Chaturvedi, V.; Yadav, S. K.; Saxena, A.; Sharma, I. Theoretical and synthetic approach to novel spiroheterocycles derived from isatin derivatives and L-proline via 1,3-dipolar cycloaddition. Heteroat. Chem.2003, 14, 36–41.10.1002/hc.10063Search in Google Scholar
[25] Kumar, R. R.; Perumala, S.; Senthilkumar, P.; Yogeeswari, P.; Sriram, D. A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines. Eur. J. Med. Chem. 2009, 44, 3821–3829.10.1016/j.ejmech.2009.05.010Search in Google Scholar PubMed
Supplemental Material:
The online version of this article offers supplementary material (https://doi.org/10.1515/hc-2017-0036).
©2017 Walter de Gruyter GmbH, Berlin/Boston
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles in the same Issue
- Frontmatter
- Review
- Chemical constituents from the genus Saussurea and their biological activities
- Preliminary Communication
- A new imidazoline-containing Bunte salt: synthesis, molecular and electronic structure
- Research Articles
- One-pot synthesis of 1-substituted 1H-1,2,3,4-tetrazoles from 2aminothiazoles using tributylmethylammonium chloride as a catalyst
- A new method for the synthesis of 4H-1,3,5-oxadiazine derivatives
- Simple access to spirooxadiazole compounds containing a quinoxaline moiety using a nitrile imine intermediate generated in situ
- A convenient regioselective synthesis of spirooxindolinopyrrolizidines incorporating the pyrene moiety through a [3 + 2]-cycloaddition reaction
- An efficient green synthesis of 5H-spiro[benzo[4,5]imidazo[1,2-c]quinazoline-6,3′-indolin]-2′-ones catalyzed by iodine in ionic liquids
- A selective fluorescence probe based on benzothiazole for the detection of Cr3+
- Spectrophotometric and quantum-chemical study of acid-base and complexing properties of (±)-taxifolin in aqueous solution
- Preparation of 1H-pyrazolo[1,2-b]phthalazine-5,10-diones using ZrO2 nanoparticles as a catalyst under solvent-free conditions
- Microwave-assisted synthesis of bis(N-substituted thiazol-2-amine) derivatives and their biological activities
Articles in the same Issue
- Frontmatter
- Review
- Chemical constituents from the genus Saussurea and their biological activities
- Preliminary Communication
- A new imidazoline-containing Bunte salt: synthesis, molecular and electronic structure
- Research Articles
- One-pot synthesis of 1-substituted 1H-1,2,3,4-tetrazoles from 2aminothiazoles using tributylmethylammonium chloride as a catalyst
- A new method for the synthesis of 4H-1,3,5-oxadiazine derivatives
- Simple access to spirooxadiazole compounds containing a quinoxaline moiety using a nitrile imine intermediate generated in situ
- A convenient regioselective synthesis of spirooxindolinopyrrolizidines incorporating the pyrene moiety through a [3 + 2]-cycloaddition reaction
- An efficient green synthesis of 5H-spiro[benzo[4,5]imidazo[1,2-c]quinazoline-6,3′-indolin]-2′-ones catalyzed by iodine in ionic liquids
- A selective fluorescence probe based on benzothiazole for the detection of Cr3+
- Spectrophotometric and quantum-chemical study of acid-base and complexing properties of (±)-taxifolin in aqueous solution
- Preparation of 1H-pyrazolo[1,2-b]phthalazine-5,10-diones using ZrO2 nanoparticles as a catalyst under solvent-free conditions
- Microwave-assisted synthesis of bis(N-substituted thiazol-2-amine) derivatives and their biological activities